Synthetic biology is the design, testing, and construction of new, standardized biological parts and devices, and programming them to do something productive. Significant medical breakthroughs are already happening as a result of advances in synthetic biology. From antiviral treatment and immune cell engineering to biomonitoring, the applications of synthetic biology are endless, creating new opportunities for innovative informatics. In this episode, we discuss revolutionary applications of synthetic biology in biopharma.
Guest: Mark Charbonneau, PhD, Director and Head of Quantitative Biology, Synlogic
Information
- Show
- FrequencyUpdated Bimonthly
- PublishedSeptember 7, 2021 at 7:07 PM UTC
- Length30 min
- Episode11
- RatingClean